Reshma Kewalramani; President, Chief Executive Officer, Director; Vertex Pharmaceuticals Inc Stuart Arbuckle; Chief Operating Officer, Executive Vice President; Vertex Pharmaceuticals Inc Charles ...
Operator Good day, and welcome to the Vertex Pharmaceuticals fourth quarter 2024 earnings call. All participants will be in a ...
Q4 2024 Earnings Call Transcript February 10, 2025 Vertex Pharmaceuticals Incorporated misses on earnings expectations. Reported EPS is $3.98 EPS, expectations were $4.02. Operator: Good day, and ...
GlobalData on MSN9d
Vertex commissions laser ore sorter at Reward gold mine in Australia"Vertex commissions laser ore sorter at Reward gold mine in Australia" was originally created and published by Mining ...
Vertex provided a revenue guidance range of $11.75 billion to $12 billion for 2025, which would amount to an increase of 6.6% to 8.9%. Management anticipates continued strong performance from its ...
stockhead on MSN10d
Vertex Minerals commissions laser ore sorterBy using ore-sorting equipment, gold ore concentrates can be created at very lowcost, creating lucrative benefits for Vertex ...
Vertex Pharmaceuticals (Nasdaq: VRTX) announced today a reimbursement agreement with NHS England for eligible sickle cell disease (SCD) patients to access the CRISPR/Cas9 gene-edited therapy, CASGEVY® ...
Bloomberg on MSN12d
New pain drug, Vertex’s Journavx, gets FDA approval as safer alternative to addictive opioidsEach year, about 125 million opioid prescriptions are written for Americans with pain caused by broken bones, burns, ...
Vertex Pharmaceuticals is a biotech company based in Boston. Its headquarters are in the Seaport neighborhood, and it also has a research site in Cambridge's Kendall Square. The company also has ...
CenExel announces its role in Vertex Pharma’s studies in Journavx and celebrates US FDA approval: Salt Lake City, Utah Saturday, February 8, 2025, 14:00 Hrs [IST] CenExel, a lea ...
StockStory.org on MSN3d
Vertex Pharmaceuticals (VRTX) Q4 Earnings Report Preview: What To Look ForBiotech company Vertex Pharmaceuticals (NASDAQ:VRTX) will be reporting results tomorrow afternoon. Here’s what to look for. Vertex Pharmaceuticals beat analysts’ revenue expectations by 3.2% last ...
Vertex began researching the drug in the 2000s ... If you purchase a product or register for an account through a link on our site, we may receive compensation. By using this site, you consent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback